🇺🇸 ESKETAMINE HYDROCHLORIDE in United States

44 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anaphylactic Shock — 11 reports (25%)
  2. Agitation — 4 reports (9.09%)
  3. Constipation — 4 reports (9.09%)
  4. Functional Gastrointestinal Disorder — 4 reports (9.09%)
  5. Urinary Hesitation — 4 reports (9.09%)
  6. Urinary Retention — 4 reports (9.09%)
  7. Weight Increased — 4 reports (9.09%)
  8. Drug Level Decreased — 3 reports (6.82%)
  9. Dysuria — 3 reports (6.82%)
  10. Suicidal Ideation — 3 reports (6.82%)

Source database →

ESKETAMINE HYDROCHLORIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is ESKETAMINE HYDROCHLORIDE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for ESKETAMINE HYDROCHLORIDE in United States?

Marketing authorisation holder not available in our data.